about
Review article: the management of autoimmune hepatitis beyond consensus guidelinesStructural basis for the cyclophilin A binding affinity and immunosuppressive potency ofE-ISA247 (voclosporin)Analysis of host-mediated repair mechanisms after human CNS-stem cell transplantation for spinal cord injury: correlation of engraftment with recoveryProgressive neurological disease induced by tacrolimus in a renal transplant recipient: case presentation.Vasospasm is a significant factor in cyclosporine-induced neurotoxicity: case report.Immunosuppressant neurotoxicity in rat brain models: oxidative stress and cellular metabolismCytapheresis in patients with severe ulcerative colitis after failure of intravenous corticosteroid: a long-term retrospective cohort study.Treating inflammatory bowel disease by adsorptive leucocytapheresis: a desire to treat without drugs.Proton Magnetic Resonance Spectroscopy in adult cancer patients with delirium.Remote communication through solute carriers and ATP binding cassette drug transporter pathways: an update on the remote sensing and signaling hypothesis.Cyclosporin and Timothy syndrome increase mode 2 gating of CaV1.2 calcium channels through aberrant phosphorylation of S6 helicesSevere fludarabine neurotoxicity after reduced intensity conditioning regimen to allogeneic hematopoietic stem cell transplantation: a case reportOxidative Stress and Liver Morphology in Experimental Cyclosporine A-Induced Hepatotoxicity.Seizures and epilepsy in oncological practice: causes, course, mechanisms and treatmentMitochondria: pharmacological manipulation of cell deathThe logics of leukocytapheresis as a natural biological therapy for inflammatory bowel disease.Regulation of drug metabolism and disposition during inflammation and infection.Biochemical mechanisms of nephrotoxicity: application for metabolomics.Immunosuppressants affect human neural stem cells in vitro but not in an in vivo model of spinal cord injury.LX211 (voclosporin) suppresses experimental uveitis and inhibits human T cells.Synergistic activity of histone deacetylase and proteasome inhibition against pancreatic and hepatocellular cancer cell lines.Posterior reversible encephalopathy syndrome in children with kidney disease.Drug choices in autoimmune hepatitis: part B--Nonsteroids.Ultrastructural examination of renal tubular epithelial cells and hepatocytes in the course of chronic cyclosporin A treatment--a possible link to oxidative stress.Neurotoxicity of immunosuppressive therapies in organ transplantation.Adacolumn leucocytapheresis for ulcerative colitis: clinical and endoscopic features of responders and unresponders.Everolimus and sirolimus in transplantation-related but different.The levels of pro-inflammatory factors are significantly decreased in cerebral palsy patients following an allogeneic umbilical cord blood cell transplant.Posterior Reversible Encephalopathy Syndrome After Transplantation: a Review.The lived experience of peripheral neuropathy after solid organ transplant.Positions of selective leukocytapheresis in the medical therapy of ulcerative colitis.Protective effect of FK506 on myocardial ischemia/reperfusion injury by suppression of CaN and ASK1 signaling circuitry.Pre- and post-treatment with cyclosporine A in a rat model of transient focal cerebral ischaemia with multimodal MRI screening.
P2860
Q26864272-C7AEF5F4-322C-46C1-A99D-E1EEB347E417Q27666620-D10A9630-8D07-4241-884B-C4CDF0A69AACQ28475604-120B9613-A68C-4241-A215-3D3D2ACB1A6FQ33238067-12DE97B4-FEA8-4ABE-9476-5DB4575C8696Q33575576-FEA8A2D9-9CC4-45D3-912B-C8AAF6E4CCCFQ33738391-2434D988-1222-4163-8A04-4669734AF4CAQ33855532-47ABA9D4-C0A8-4397-848B-105A781BAB14Q34008773-DDE12D65-FB78-439B-97B8-82BB83ED26F5Q34538255-5F740D31-6FAB-4235-B8A9-6257F1D8A264Q34865706-00017269-2EC8-4273-BFF0-2389BAB1411AQ34944217-2782E774-F4F8-494D-8B45-208C8AE8C64FQ35924914-FF6FFB99-DF45-4080-814D-6982D71138E2Q36051438-9355C16E-E8A9-45B2-AC42-0F1EA050AE04Q36143358-450D6DE7-F8B4-4A89-BC69-50D27E76A1C2Q36274960-FA742056-9ACD-464D-A284-4A341BC6F4B7Q36446929-4282465E-63FA-4864-BA3E-2C323FF31933Q36544874-A2A12D90-01A6-448A-B71A-25E64BE0C127Q36909319-4B71891D-58A3-48D6-9695-D5E90D4E71BFQ37202715-F0172EAC-026A-491B-A528-E3839E2B6471Q37361237-44BDED2A-5E1A-4D1A-9910-B8CA2FCD1941Q37400663-4B621025-4348-4C9F-B30D-C0E2477B8F25Q37589780-73F42F81-AC6E-44B8-9711-6BAE9036834CQ38051706-D226A7AF-4B8C-4659-A04B-B939D1292C35Q38123233-C75F5298-B286-428B-ABF5-F9CAB5E56A75Q38174059-7A3A596D-41C0-49BC-98B0-D7E4859E6B65Q38243723-590E2324-AD02-4008-9FC6-E3494420F4B8Q38442560-7B23D9BC-5EF6-4530-AF1B-5F96C462D72AQ38463054-E7B6C531-78B4-4EBB-AF47-9FA7A79D9D51Q38669053-8881AF97-DB47-4D2B-9E72-6D201C3B2E13Q39242390-4AA1A12A-679A-426F-A5F3-14B2ED322F82Q42726307-3B6089C4-FE65-454C-81CE-C923C1F8A31DQ53289472-ED6F5A94-0753-4F0A-A1B6-7AA4FD54CEEBQ54429660-3297CB13-C916-4B8E-AB3D-964985CC2197
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Biochemical mechanisms of cyclosporine neurotoxicity.
@ast
Biochemical mechanisms of cyclosporine neurotoxicity.
@en
type
label
Biochemical mechanisms of cyclosporine neurotoxicity.
@ast
Biochemical mechanisms of cyclosporine neurotoxicity.
@en
prefLabel
Biochemical mechanisms of cyclosporine neurotoxicity.
@ast
Biochemical mechanisms of cyclosporine neurotoxicity.
@en
P2093
P356
P1476
Biochemical mechanisms of cyclosporine neurotoxicity.
@en
P2093
Leslie Z Benet
Natalie J Serkova
Uwe Christians
P304
P356
10.1124/MI.4.2.7
P577
2004-04-01T00:00:00Z